Biolexis Therapeutics to Present Five Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024

AMERICAN FORK, Utah, April 1, 2024 /PRNewswire/ — Biolexis Therapeutics, Inc. a clinical-stage biopharmaceutical company with a novel AI-assisted drug discovery platform technology, today announced it will present five posters at the 2024 American Association for Cancer Research (AACR),…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks